Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Capricor Therapeutics (CAPR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to 0.22.

  • Capricor Therapeutics' Asset Utilization Ratio fell 4856.84% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 4856.84%. This contributed to the annual value of 0.35 for FY2024, which is 2457.08% down from last year.
  • Capricor Therapeutics' Asset Utilization Ratio amounted to 0.22 in Q3 2025, which was down 4856.84% from 0.22 recorded in Q2 2025.
  • In the past 5 years, Capricor Therapeutics' Asset Utilization Ratio ranged from a high of 0.74 in Q2 2024 and a low of 0.0 during Q1 2022
  • For the 5-year period, Capricor Therapeutics' Asset Utilization Ratio averaged around 0.22, with its median value being 0.2 (2023).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 9440.17% in 2021, then surged by 267357.58% in 2023.
  • Over the past 5 years, Capricor Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then skyrocketed by 745.62% to 0.05 in 2022, then soared by 970.54% to 0.53 in 2023, then crashed by 34.81% to 0.34 in 2024, then tumbled by 35.16% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.22 for Q2 2025, and 0.22 during Q1 2025.